asper1971

The IC Chat

Health EN ↓ 25 episodes

Intended to help Interventional Cardiologists with critical appraisal of clinical trials

Be sure to visit the podcast's website and support the creator: asper1971.podbean.com

Author

asper1971

Category

Health

Podcast website

asper1971.podbean.com

Latest episode

Nov 7, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

P4 Trial Deep Dive: Can CT Pre-Planning Replace IVUS in PCI? 07.11.2026

Host Ashish Pershad reviews the P4 trial (TCT 2026/NEJM), which compared pre-procedural CCTA-based planning with CT-derived FFR and plaque analysis versus IVUS-guided PCI. The episode breaks down study design, patient selection, endpoints, and key results. The trial met non-inferiority at 12 months with similar target-vessel failure rates (4.1% CCTA vs 4.6% IVUS). Dr. Prasad discusses criticisms—w...

PVI vs Placebo: When Ablation Fails to Beat the Sham 24.10.2026

Host Ashish Pershad examines the PVI‑SHAM‑AF sham‑controlled trial, explaining trial design, blinding, and endpoints for catheter ablation in symptomatic atrial fibrillation. The episode summarizes key results: ablation markedly reduced AF burden and recurrences but did not show superior quality‑of‑life improvement over an active sham at 6 months, highlighting a disconnect between objective rhythm...

REBOOT PARADOX: Does TAVR Improve Outcomes in Paradoxical Low‑Flow, Low‑Gradient AS? 29.09.2026

In this episode host Ashish Pershad reviews and critically appraises the REBOOT PARADOX randomized trial of TAVR versus optimal medical therapy in patients with paradoxical low‑flow, low‑gradient severe aortic stenosis. He summarizes trial design, patient selection, methods, and the challenges that led to early termination and underpowering. Key findings discussed include excellent hemodynamic rel...

Functional Angio vs. Angio-Only: AIR-STEMI and Culprit alone versus Complete PCI in STEMI with MVD 07.09.2026

Host Ashish Pershad breaks down the AIR-STEMI (ARISTEMI) trial presented at ESC, explaining how physiology-guided (functional angiography) complete revascularization compares to angiography-guided approaches in STEMI patients with multivessel disease. He reviews study design, key results showing fewer events and safer outcomes with functional guidance, limitations, and practical takeaways for inte...

LAA Occlusion vs DOACs: Meta-Analysis Sparks Debate and is IVL superior to RA for calcified lesions 15.08.2026

Host Ashish Prasad critically appraises two important interventional cardiology studies: a Taiwanese meta-analysis of four randomized trials comparing left atrial appendage occlusion to DOACs, and the ICARE randomized trial comparing intravascular lithotripsy (IVL) with rotational atherectomy for calcified coronary lesions. The meta-analysis found no overall difference in stroke but a non-signific...

Leave Nothing Behind? The Real Story on Drug‑Eluting Balloons 15.07.2026

In this episode of IC Chat, host Ashish Pershad reviews drug‑eluting balloons for coronary disease, appraising two landmark trials: AGENT‑IDE (in‑stent restenosis) and SOLUTION de novo (de novo lesions). He explains device pharmacology (paclitaxel vs. sirolimus), trial designs and results, practical considerations for vessel preparation and imaging, and offers cautious clinical takeaways about whe...

RESHAPE HF II vs COAPT & MITRAL‑FR: Unraveling the MitraClip Debate 01.06.2026

Welcome to IC Chat with host Dr. Ashish Pershad. In this episode we examine the controversial role of transcatheter edge-to-edge mitral valve repair for functional mitral regurgitation, focusing on the COAPT, MITRAL‑FR and the newer RESHAPE Heart Failure II trials. We summarize trial differences in patient selection, anatomy (EROA and LV volumes), outcomes (heart failure hospitalizations, quality...

ORBITA CTO: The Sham-Controlled Trial That Shook CTO-PCI 10.05.2026

In this episode host Ashish Pershad reviews the ORBITA CTO randomized, double-blind, sham-controlled trial that compared CTO-PCI to a placebo procedure, explaining the rigorous design, patient selection, masking methods, and statistical approach. Pershad summarizes the results showing significant symptom improvement with CTO-PCI, discusses clinical implications—blinding, careful case selection, an...

The IC CHAT episode 17 —Is the MFP necessary for all HR-PCI cases? CHIP-BCIS answers this very question 20.04.2026

Host Dr. Ashish Pershad introduces IC Chat’s mission to help clinicians interpret evidence-based medicine and translate trial data into everyday patient care. In this episode he appraises the CHIP-BCIS-3 randomized trial (ACC 2026 / NEJM) comparing prophylactic microaxial flow pump (Impella) versus standard care in very high‑risk elective PCI patients. The trial enrolled patients with low LVEF and...

CHAMPION‑AF Decoded: Watchman Flex vs DOACs 29.03.2026

In this episode of ICChat, Dr. Ashish Pershad MD MS  reviews and critiques the CHAMPION‑AF trial comparing Watchman Flex left atrial appendage occlusion to DOACs for atrial fibrillation. He explains the trial design, endpoints, and statistical choices, and contrasts the published results with real‑world implications. The episode highlights concerns about non‑inferiority margins, excluded procedura...

Long term TAVR data 02.03.2026

Critical appraisal of the 6-year Evolut low risk trial data and a one on one with Steve Yakubov one of the senior authors on the paper for his take on TAVR adoption in low-risk patients

IC CHAT Episode 13-SHORTCUT and VICTORY Trials 23.01.2026

Appraisal of the SHORTCUT and VICTORY trials comparing IVL to CB and OPN balloons plus a bonus interview with Ajay Kirtane MD deconstructing the trials

THE IC CHAT -CREST 2 Trial 13.12.2025

A critical appraisal of the CREST 2 clinical trial 4-year outcomes comparing carotid revascularization with current medical therapy in asymptomatic patients with high grade carotid artery stenosis. 

The IC Chat -Encircle Trial 24.11.2025

A critical appraisal of ENCIRCLE and a follow up interview with Encircle Co-PI David Daniels MD make for an interesting episode. 

IC CHAT episode 11 - Transcatheter treatment of pure AI 02.11.2025

A Critical appraisal of dedicated TAVR valve trials for AI and a general overview of the status of AI treatment in 2025. 

IC Chat Episode 10 - BEV vs SEV in Bicuspid Aortic Valve Stenosis 23.09.2025

A deep dive into bicuspid aortic valve stenosis and the choice of BEV vs SEV- A propensity matched observational study critically appraised.

IC CHAT Episode 9- IVI in Contemporary PCI 01.09.2025

A deep dive into 2 network metanalysis looking at IVI in contemporary PCI. 

IC Chat Episode 8- PLATO and all the controversy associated with it 30.07.2025

A critical appraisal of PLATO (Ticagrelor versus Clopidogrel) and the recent controversies 

IC CHAT Episode 7 - TAP IT TRIAL 22.06.2025

A decades long practice of routinely tapping effusions upfront in patients with heart failure is challenged with this simple and elegantly conducted clinical trial from Denmark. The TAP IT clinical trial is critically appraised in this month's edition of IC CHAT

IC CHAT Episode 6- FAME 3 Clinical Trial 20.05.2025

Critical appraisal of the FAME 3 Clinical Trial 5-year data presented at ACC 2025

PROTECTED TAVI TRial 20.04.2025

A critical appraisal of the Protected TAVI trial, comparing Cerebral Embolic Protection with standard of care for routine TAVR cases. Bibliography: 1. Kharbanda RK, Kennedy J, Jamal Z et al; BHF PROTECT-TAVI Investigators. Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation. N Engl J Med. 2025 Mar 30. 2. Angrist JD, Gao C, Hull P, Yeh RW. Instrumental Variables in Ra...

IC Chat Episode 4 : TRISCEND 2 23.03.2025

A critical appraisal of a RCT comparing transcatheter tricuspid valve replacement to medical treatment in patients with symptomatic severe tricuspid regurgitation. 

IC Chat Episode 3 DANGERSHOCK Trial 18.02.2025

A critical appraisal of the DANGER SHOCK Trial comparing the micro-axial flow pump Impella CP with standard of care in patients with acute myocardial infarction complicated by cardiogenic shock

IC CHAT Episode 2 28.01.2025

A critical appraisal of the OPTION trial comparing a strategy of AF ablation plus LAAO versus AF ablation plus DOACS.

IC Chat - Episode 1: Early TAVR 25.12.2024

An opportunity for practicing Interventional Cardiologists to critically appraise the Early TAVR trial - A strategy trial comparing TAVR to clinical surveillance in asymptomatic patients with severe Aortic valve stenosis. This podcast is intended for health care professionals and practicing cardiologists. **The Start of Something Beautiful by Ketsa is licensed under an Attribution-Non Commercial n...

Listen to the The IC Chat podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.